As pharmaphorum reported, Sanofi’s CEO Paul Hudson sparked a major political controversy yesterday by saying that the US would have first rights to the company’s potential COVID-19 vaccine because it had invested most in the project.
President Emmanuel Macron has summoned Hudson and Sanofi’s top management to a meeting next week to explain themselves after a health minister said it was “unacceptable” for the US to be prioritised.
privacy policy | terms of use | contact us | advertise | pharma jobs | pharma blogs | facebook | twitter
Copyright © 2024,